Michael Greco V - 03 Feb 2026 Form 4 Insider Report for Veradermics, Inc (MANE)

Role
General Counsel
Signature
/s/ Michael Greco
Issuer symbol
MANE
Transactions as of
03 Feb 2026
Net transactions value
$0
Form type
4
Filing time
05 Feb 2026, 19:02:28 UTC
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Michael Greco V filed Form 4 for Veradermics, Inc (MANE) on 05 Feb 2026."

Quick Takeaways

  • This page summarizes Michael Greco V's Form 4 filing for Veradermics, Inc (MANE).
  • 1 reported transaction and 1 derivative row are listed below.
  • Filing timestamp: 05 Feb 2026, 19:02.

What Changed

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Greco Michael V. General Counsel C/O VERADERMICS, INCORPORATED, 470 JAMES ST., NEW HAVEN /s/ Michael Greco 05 Feb 2026 0001786766

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MANE Stock Option (Right to Buy) Award $0 +144,401 $0.000000 144,401 03 Feb 2026 Common Stock 144,401 $17.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the underlying shares of the Issuer's common stock, par value $0.00001 per share, on February 3, 2027, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal monthly installments over 36 months thereafter, subject to continued service.

Sponsored